UPPSALA June 29, 2020 – Coala Life and the pharmaceutical company Bayer AB are expanding their collaboration to scale up operations in an effort to streamline the Swedish patient flow at a time when the healthcare system is under pressure. Coala Connect, a digital home-enrollment program for a healthcare service that enables remote arrhythmia assessments …
Stockholm, Sweden and Irvine, CA, US, April 15th, 2020 – Coala Life, the pioneer in remote and real-time cardiac monitoring solutions, today announces expanded functionality of the Coala Heart Monitor allowing for remote lung auscultation using the existing integrated digital stethoscope. The Coala has recently been made available in the US for home enrolled cardiac …
Donald has a family history of heart disease. Since his late 40’s, he’s been troubled by sporadic arrythmias that have come and gone. Thanks to the Coala Heart Monitor, though, he is now properly diagnosed and enjoying a healthy life as a retired engineer. “The first time the heart struck me was back in …
A new peer-reviewed article in the scientific journal Expert Review of Medical Devices profiles the Coala Heart Monitor by researchers and clinicians of the Karolinska Institutet and Karolinska University Hospital, Stockholm. The article reviews the proprietary dual-lead ECGs and algorithms for automatic interpretation of heart rhythms based on both RR-dispersion and P-wave morphology to diagnose …
Stockholm, January 7, 2020 – Swedish digital health company Coala Life today announced a research and development partnership with Asahi Kasei Corporation in Japan. The collaboration includes a development program and feasibility research targeting Heart Failure (HF) patients in Japan. Nearly one million patients are suffering from Heart Failure (HF) in Japan. The country also has the …
IRVINE, December 19, 2019 – The High Desert Heart Institute in California, part of nationwide Prime Healthcare group, has signed a partnership with Coala Life to utilize the Coala Heart Monitor on a broad scale. The agreement constitutes the first major healthcare provider contract for Coala Life in the US following recent market launch. Clinical …
STOCKHOLM, DECEMBER 11, 2019 – In order to continue our strategic drive to grow the health care business and align our sales and marketing efforts the role Chief Commercial Officer has been created. With the recent FDA clearance for Coala in the US and the subsequent launch in the US, Germany and soon the Netherlands, …
STOCKHOLM, November 22, 2019 – Implementation of the Coala Heart Monitor leads to higher clinical efficiency, lower costs, shorter waiting lists and higher patient satisfaction. That is the results of a clinical evaluation performed at the Cardiology Clinic at Aleris Sabbatsberg. In 2019, Aleris Cardiology Clinic at Sabbatsberg hospital used Coala Heart Monitor to …
STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets. The Swedish medtech company Coala Life, …
